Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib Adjuvant Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
CTR20131405Phase 3Suspended
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of afatinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Boehringer Ingelheim. Started Oct 2014; status: suspended.
02
Drugs
afatinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on CTR20131405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131405.